Physician profile
Anthony Ardito
NPI 1508829664
$1,844.03
in general payments reported to CMS, 2019-2025
19 companies · $665 in 2025
The $665 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.38 · 2020: $249 · 2021: $96.11 · 2022: $138 · 2023: $310 · 2024: $321 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $288.83 | 2020-2025 | Wegovy, Ozempic |
| Abbott Laboratories | $232.37 | 2023-2025 | Freestyle Libre 3, Aveir, Mitraclip |
| Novartis Pharmaceuticals Corporation | $217.92 | 2021-2025 | |
| Recor Medical INC | $173.54 | 2025 | Paradise Ultrasound Renal Denervation System |
| Merck Sharp & Dohme LLC | $167.98 | 2019-2021 | |
| Pfizer INC. | $138.96 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $131.91 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.77 | 2020-2025 | Jardiance |
| Glaxosmithkline, LLC. | $87.15 | 2021-2025 | Arexvy, Shingrix |
| Opko Pharmaceuticals, LLC | $50.30 | 2021-2025 | Rayaldee |
| Amarin Pharma, INC. | $38.46 | 2019 | |
| Intuity Medical INC | $37.85 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Abbvie INC. | $27.76 | 2024-2025 | |
| Boston Scientific Corporation | $26.68 | 2023 | Varithena Administration Pack |
| Kowa Pharmaceuticals America, INC. | $25.15 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $25.00 | 2025 | Unithroid |
| Madrigal Pharmaceuticals | $24.24 | 2025 | Rezdiffra |
| Medtronic, INC. | $20.59 | 2024 | Minimed 780g |
| Amgen INC. | $16.57 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Ardito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.